Drug Repurposing for Cancer Therapy in the Era of Precision Medicine
Author:
Affiliation:
1. School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
2. Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China
Abstract
Funder
Food and Health Bureau of Hong Kong Government
Publisher
Bentham Science Publishers Ltd.
Subject
General Health Professions
Reference71 articles.
1. Moreno L.; Pearson A.D.; How can attrition rates be reduced in cancer drug discovery? Expert Opin Drug Discov 2013,8(4),363-368
2. Zhang Z.; Zhou L.; Xie N.; Nice E.C.; Zhang T.; Cui Y.; Huang C.; Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 2020,5(1),113
3. Nowak-Sliwinska P.; Scapozza L.; Ruizi A.A.; Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer. Biochim Biophys Acta Rev Cancer 2019,1871(2),434-454
4. Nosengo N.; Can you teach old drugs new tricks? Nature 2016,534(7607),314-316
5. Hernandez J.J.; Pryszlak M.; Smith L.; Yanchus C.; Kurji N.; Shahani V.M.; Molinski S.V.; Giving drugs a second chance: Overcoming regulatory and financial hurdles in repurposing approved drugs as cancer therapeutics. Front Oncol 2017,7,273
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer;Pharmaceuticals;2023-12-21
2. Repurposing of approved drugs for targeting CDK4/6 and aromatase protein using molecular docking and molecular dynamics studies;PLOS ONE;2023-09-08
3. MET-Targeting Anticancer Drugs—De Novo Design and Identification by Drug Repurposing;Drugs and Drug Candidates;2023-07-18
4. Repurposing of the Drug Tezosentan for Cancer Therapy;Current Issues in Molecular Biology;2023-06-11
5. 5‐Nitrofuryl‐Containing Thiosemicarbazone Gold(I) Compounds: Synthesis, Stability Studies, and Anticancer Activity;ChemPlusChem;2023-05-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3